SUN-155 Clinical Experience of SGLT2 Inhibitors in a Hispanic Population: Should We Consider Its Use as Add-On Treatment?

Introduction: 1 in 11 adults have DM globally,(1) and Hispanics have higher complication rates.(2) A study determined that ~$16,750/year are spent by patients in medical related costs, of which ~$9,600 are related to diabetes.(3) Half of Type 2 Diabetes Mellitus (T2DM) patients aren't achieving...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Endocr Soc
Hlavní autoři: Zayas, Francisco, Iriarte, R, Vergne, Norma, Hernandez, Luis, Gonzalez, Alex, Mangual, Michelle
Médium: Artigo
Jazyk:Inglês
Vydáno: Endocrine Society 2019
Témata:
Diabetes Mellitus and Glucose Metabolism
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6553393/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/js.2019-SUN-155
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky